Sensorion Announces the Completion of Its Reverse Share Split
Regulatory News:Sensorion (FR001401A9Z0 — ALSEN) (“the Company”), a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announces the completion of the reverse share split of the shares compos…